Why the study?
Does a controlled hyperemia test reduce shear rate and flow-mediated dilation variability compared to the standard reactive hyperemia test in healthy subjects?
Does a controlled hyperemia test reduce shear rate and flow-mediated dilation variability compared to the standard reactive hyperemia test in healthy subjects?
Controlling shear rate during flow-mediated dilation testing reduces between-subject variability and eliminates the confounding effect of baseline arterial diameter, improving the reliability of endothelial function assessment.
No takes yet. Share an insight, caveat, or question.
May improve FMD reliability in research; leaves open clinical adoption pending validation.
Pyke et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: